» Articles » PMID: 22948488

EuroFlow: Resetting Leukemia and Lymphoma Immunophenotyping. Basis for Companion Diagnostics and Personalized Medicine

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2012 Sep 6
PMID 22948488
Citations 27
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China.

Leung K, Cai J, Liu Y, Chan K, Shao J, Yang H Leukemia. 2023; 38(2):250-257.

PMID: 38001171 PMC: 10844073. DOI: 10.1038/s41375-023-02089-3.


Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.

Schneider P, Crump N, Arentsen-Peters S, Smith A, Hagelaar R, Adriaanse F Exp Hematol Oncol. 2023; 12(1):81.

PMID: 37740239 PMC: 10517487. DOI: 10.1186/s40164-023-00445-8.


Immunophenotypic characterization of acute leukemias in Bahia, Brazil.

Santos M, Santos A, Santos H, Santos L, Nascimento R, Torres A Einstein (Sao Paulo). 2023; 21:eAO0117.

PMID: 36629681 PMC: 9785573. DOI: 10.31744/einstein_journal/2023AO0117.


"Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow.

Pacelli P, Raspadori D, Bestoso E, Gozzetti A, Bocchia M Front Oncol. 2022; 12:1057713.

PMID: 36518304 PMC: 9742464. DOI: 10.3389/fonc.2022.1057713.


Diagnostic challenges in acute monoblastic/monocytic leukemia in children.

Varotto E, Munaretto E, Stefanachi F, Della Torre F, Buldini B Front Pediatr. 2022; 10:911093.

PMID: 36245718 PMC: 9554480. DOI: 10.3389/fped.2022.911093.


References
1.
Serke S, Schwaner I, Yordanova M, Szczepek A, Huhn D . Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry. 2001; 46(2):98-104. DOI: 10.1002/cyto.1071. View

2.
Rawstron A, Villamor N, Ritgen M, Bottcher S, Ghia P, Zehnder J . International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia. 2007; 21(5):956-64. DOI: 10.1038/sj.leu.2404584. View

3.
Wood B, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick S . 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom. 2007; 72 Suppl 1:S14-22. DOI: 10.1002/cyto.b.20363. View

4.
Basso G, Buldini B, De Zen L, Orfao A . New methodologic approaches for immunophenotyping acute leukemias. Haematologica. 2001; 86(7):675-92. View

5.
Dekking E, van der Velden V, Varro R, Wai H, Bottcher S, Kneba M . Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia. Leukemia. 2012; 26(9):1976-85. PMC: 3437408. DOI: 10.1038/leu.2012.125. View